American International Group, Inc. (AIG)

American International Group's stock closed at $82.85 on November 11, 2026, up 0.64% on the session, and sits 72% of the way up its 52-week range. The move follows a November 3, 2026 report in which adjusted EPS of $2.06 beat the analysts' estimate of $1.88 by 9.57%, and the stock rose 1.47% in the next session. Wells Fargo kept its Equal-Weight rating on November 5, 2026. The stock is trading above its 20-day EMA, 50-day and 200-day averages, so the trend is up while revenue growth has lagged the sector.

The November 3, 2026 report was the clearest recent event. Adjusted EPS of $2.06 beat the analysts' estimate of $1.88 by 9.57%, and the stock rose 1.47% in the first session after the report. The company has beaten EPS estimates in all eight reports it has issued over the period, the most recent before November 3 being August 6, 2026, when a beat of 3.63% was followed by a 1.49% drop. Beats have not reliably lifted the stock: three of the eight beats were followed by a lower price in the first session.

At a trailing P/E of 13.52, the stock trades 18.1% below the sector median of 16.5, a gap that is broadly in line with peers. The price-to-sales ratio of 1.54 is 59.6% below the sector median of 3.8. The gap is wider on sales than on earnings, which reflects a net profit margin of 11.8% and an operating margin of 18.21%.

Revenue grew 0.64% in the latest quarter compared with the same quarter a year earlier, 11.1 percentage points slower than the sector median of 11.7%. Return on equity of 8.23% is below the sector median of 13.8%. The balance sheet is less stretched, with a debt-to-equity ratio of 0.27, and the company's health is rated 3 of 5.

Of 22 analysts with a current rating, 8 rate the stock buy or strong buy, 14 hold and none sell. Three months ago 8 of 22 rated it buy, so the mix is unchanged. Wells Fargo kept its Equal-Weight rating on November 5, 2026, and on October 12, 2026, while Keefe, Bruyette & Woods kept its Outperform rating on October 12, 2026. Insiders sold $23.6M of stock over the last 18 months, against open-market purchases of $56K.

Base case for the coming months: the stock keeps trading above its moving averages as long as earnings keep beating estimates and the trend holds. Analysts' estimates point to EPS growth of 15.8% this fiscal year and 7.2% next year, to $8.21 and $8.80. The median 12-month analyst target is $89.00, 7.4% above the current price, with a range from $80.00 to $101.00. Upside depends on revenue growth picking up from the 0.64% reported in the latest quarter, which trails the sector median of 11.7%. A break below the 20-day EMA would weaken the near-term picture, and a fall toward the 200-day average would test the trend more seriously. Simulations from past volatility are not forecasts, and the stock's typical daily move is 1.55%.

Support sits at the 20-day EMA of $80.39, the nearest level below the price. Below it is the 50-day SMA at $77.78, then the 200-day SMA at $77.14. The 52-week low of $71.25 is the furthest support level. Resistance is the 52-week high of $87.29, the nearest level above the price and the level a rise would meet first.